Inventor · disambiguated record
Ulrich Steidl
Also filed as: STEIDL ULRICH · STEIDL ULRICH G
7 granted patents·8 pending applications·4 citations·filing 2012–2024
73Inventor score
Files withALBERT EINSTEIN COLLEGE MEDICINE9STEIDL ULRICH G3EINSTEIN COLL MED2ALBERT EINSTEIN COLLEGE MEDICINE INC1
Top patents by PatentIndex Score
15 records- 0182US11382898B2BAX activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Jul 12, 2022·2 cites·13 claims
- 0275US2025032462A1Bax activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 0369US12016845B2BAX activators and uses thereof in cancer therapyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Granted Jun 25, 2024·0 cites·25 claims
- 0467US9873918B2Treatment of acute myeloid leukemia and myelodysplastic syndromesSTEIDL ULRICH G·Filed 2012·Granted Jan 23, 2018·2 cites·10 claims
- 0554US10941209B2Identification and use of new tumor-promoting gene in hematological malignanciesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Mar 9, 2021·0 cites·3 claims
- 0654US2016340737A1Epigenetic stem cell commitment-associated signatureALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2014·Application pending·0 cites
- 0747US2014187604A1Therapeutic and diagnostic target gene in acute myeloid leukemiaSTEIDL ULRICH G·Filed 2012·Application pending·0 cites
- 0847US2015329643A1Identification and use of new tumor-promoting gene in hematological malignanciesEINSTEIN COLL MED·Filed 2013·Application pending·0 cites
- 0944US2022227886A1Antibody-based method to identify, purify, and manipulate cell types and processesALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1043US2021355501A1Interleukin-8 for maintenance of human acute myeloid leukemia and myelodysplastic syndrome and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1140US2015299336A1Therapeutic and diagnostic target gene in acute myeloid leukemiaSTEIDL ULRICH G·Filed 2015·Application pending·0 cites
- 1237US11065251B2PAK1 inhibitors and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted Jul 20, 2021·0 cites·34 claims
- 1337US10774049B2PU.1 inhibitorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Sep 15, 2020·0 cites·27 claims
- 1430US11137397B2Peptides for blocking IL1RAP protein-protein interaction and uses thereof for treatment of diseaseALBERT EINSTEIN COLLEGE MEDICINE·Filed 2015·Granted Oct 5, 2021·0 cites·4 claims
- 1529US2015359815A1Pak1 inhibition for treatment of acute myeloid leukemia and myelodysplastic syndromesEINSTEIN COLL MED·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Steidl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →